StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb (BMY) Reports Clinical Trial Collaboration with Advantagene Inc.
April 27, 2018 7:16 AM
Advantagene, Inc. today announced that the company entered into a clinical trial collaboration with Bristol-Myers Squibb (NYSE: BMY) to evaluate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Management Comments
Next Articles
Advantagene Announces Clinical Trial Collaboration
April 27, 2018 7:00 AM
Bristol-Myers Squibb Co. (BMY) PT Lowered to $55 at Barclays
April 27, 2018 4:14 AM
BMO Capital Upgrades Bristol-Myers Squibb Co. (BMY) to Market Perform Citing More Balanced Risk/Reward
April 27, 2018 4:10 AM
Bristol-Myers Squibb (BMY) Tops Q1 EPS by 9c; Raises Outlook
April 26, 2018 7:01 AM
Bristol-Myers Squibb (BMY) Says EC Approved its Opdivo Four-Week Dosing Schedule for Advanced Melanoma and Previously Treated Renal Cell Carcinoma
April 25, 2018 4:37 PM
Bristol-Myers Squibb Co. (BMY) PT Lowered to $62 at Citi
April 25, 2018 6:45 AM
Shire bid marks Takeda's latest - and biggest - push for global status
April 25, 2018 5:39 AM
